Axiom mission can prove to be important for diabetes patients; Know what astronauts will study in space
Under the 'Suit Ride' experiment of UAE healthcare provider Burjeel Holdings and Axiom Space, astronauts will wear glucose monitors during their 14-day space journey during the Axiom mission. The astronauts will study the behavior of glucose in microgravity or negligible gravity.



The Axiom-4 mission, taking Indian astronaut ShubhanshuShukla to the International Space Station (ISS), provides hope that space travel would not be out of bounds for diabetes patients. Axiom-4: Astronauts will examine how glucose acts in microgravity/low gravity.
Insulin-dependent diabetics are currently banned by the National Aeronautics and Space Administration (NASA) from traveling in space. Non-insulin dependent diabetes is not an official disqualifier, but no diabetic astronaut has traveled in space so far.
Under the 'Suit Ride' experiment by UAE healthcare provider Burjeel Holdings and Axiom Space, astronauts on the Axiom mission will wear glucose monitors during their 14-day space journey. Studying the behaviour of glucose and insulin in microgravity will help scientists develop wearable technologies for astronauts and patients who are bedridden due to diseases such as paralysis.





































.jpeg)



























































































